These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 6935185)

  • 1. Guidelines for simple, sensitive significance tests for carcinogenic effects in long-term animal experiments.
    Peto R; Pike MC; Day NE; Gray RG; Lee PN; Parish S; Peto J; Richards S; Wahrendorf J
    IARC Monogr Eval Carcinog Risk Chem Hum Suppl; 1980; (2 Suppl):311-426. PubMed ID: 6935185
    [No Abstract]   [Full Text] [Related]  

  • 2. Basic requirements for long-term assays for carcinogenicity.
    Feron VJ; Grice HC; Griesemer R; Peto R; Agthe C; Althoff J; Arnold DL; Blumenthal H; Cabral JR; Della Porta G; Ito N; Kimmerle G; Kroes R; Mohr U; Napalkov NP; Odashima S; Page NP; Schramm T; Steinhoff D; Sugar J; Tomatis L; Uehleke H; Vouk V
    IARC Monogr Eval Carcinog Risk Chem Hum Suppl; 1980; (2 Suppl):21-83. PubMed ID: 6935180
    [No Abstract]   [Full Text] [Related]  

  • 3. Statistical issues in interpretation of chronic bioassay tests for carcinogenicity.
    Gart JJ; Chu KC; Tarone RE
    J Natl Cancer Inst; 1979 Apr; 62(4):957-74. PubMed ID: 285297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reproducibility of results in "near-replicate" carcinogenesis bioassays.
    Gold LS; Wright C; Bernstein L; deVeciana M
    J Natl Cancer Inst; 1987 Jun; 78(6):1149-58. PubMed ID: 3473255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Semiparametric analysis of tumor incidence rates in survival/sacrifice experiments.
    Portier CJ; Dinse GE
    Biometrics; 1987 Mar; 43(1):107-14. PubMed ID: 3567301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimation of "safe doses" in carcinogenic experiments.
    Hartley HO; Sielken RL
    J Environ Pathol Toxicol; 1977; 1(2):241-78. PubMed ID: 553133
    [No Abstract]   [Full Text] [Related]  

  • 7. Uncertainty estimates for low-dose-rate extrapolations of animal carcinogenicity data.
    Guess H; Crump K; Peto R
    Cancer Res; 1977 Oct; 37(10):3475-83. PubMed ID: 908002
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies on the mechanism of the synergistic carcinogenic response reported between ethylene and disulfiram and the implications for short term predictive screening tests.
    Elliott BM; Ashby J
    Dev Toxicol Environ Sci; 1980; 8():193-6. PubMed ID: 7030702
    [No Abstract]   [Full Text] [Related]  

  • 9. Long-term and short-term screening assays for carcinogens: a critical appraisal.
    IARC Monogr Eval Carcinog Risk Chem Hum Suppl; 1980; (2 Suppl):1-426. PubMed ID: 6935176
    [No Abstract]   [Full Text] [Related]  

  • 10. Design of cancer assays for pharmaceutical agents: a reply.
    Boorman GA; Huff JE; Schwetz BA
    J Natl Cancer Inst; 1986 Aug; 77(2):589-90. PubMed ID: 3461218
    [No Abstract]   [Full Text] [Related]  

  • 11. Assessment of interaction between carcinogens in long-term factorially designed animal experiments.
    Machado SG; Bailey KR
    Biometrics; 1985 Jun; 41(2):539-45. PubMed ID: 4027328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Statistical methods in the study of carcinogenicity in animal experiments].
    Maksimovich DM; Parfenov IuD
    Vopr Onkol; 1990; 36(3):276-85. PubMed ID: 2184580
    [No Abstract]   [Full Text] [Related]  

  • 13. Environmental cancer: animal studies and assay procedures.
    Griffin AC
    Tex Rep Biol Med; 1978; 37():45-9. PubMed ID: 752984
    [No Abstract]   [Full Text] [Related]  

  • 14. Possible methods of carcinogenicity testing for substances used at the place of work.
    Steinhoff D
    Cancer Detect Prev; 1981; 4(1-4):41-6. PubMed ID: 7349803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response to "use of Statistics when Examining Lifetime Studies in Rodents to Detect Carcinogenicity".
    Fears TR; Tarone RE
    J Toxicol Environ Health; 1977 Nov; 3(4):629-32. PubMed ID: 592430
    [No Abstract]   [Full Text] [Related]  

  • 16. A Bayesian approach to the multiplicity problem for significance testing with binomial data.
    Meng CY; Dempster AP
    Biometrics; 1987 Jun; 43(2):301-11. PubMed ID: 3607202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conservatism of the approximation sigma (O-E)2-E in the logrank test for survival data or tumor incidence data.
    Peto R; Pike MC
    Biometrics; 1973 Sep; 29(3):579-84. PubMed ID: 4793138
    [No Abstract]   [Full Text] [Related]  

  • 18. [The possible carcinogenic properties of riboxin (inosie F)].
    Vlasov NN; Pliss GB; Anikin IV
    Vopr Onkol; 1992; 38(8):942-9. PubMed ID: 1300804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemical carcinogens: screening, testing, risk assessment for man.
    Schramm T; Teichmann B
    Neoplasma; 1981; 28(2):129-31. PubMed ID: 7254431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medium-term bioassays in rats for rapid detection of the carcinogenic potential of chemicals.
    Shirai T; Hirose M; Ito N
    IARC Sci Publ; 1999; (146):251-72. PubMed ID: 10353390
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.